Cerus (CERS) Return on Assets (2011 - 2026)

Cerus (CERS) posted Return on Assets of 0.0% for Q2 2026, up 29.79% sequentially from 0.0% in Q1 2026, and little changed YoY from 0.0% in Q2 2025.

Cerus (CERS) Return on Assets (2011 - 2026) Analysis & Trends

Cerus has reported Return on Assets for 16 years, with the latest figure at 0.0% in Q2 2026.

Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Assets advanced to 0.0% in Q2 2026 per CERS's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Assets peaked at 0.0% in Q2 2026 and troughed at 0.0% in Q2 2023.
A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
The widest YoY moves for Return on Assets: up 0 bps in 2022, down 0 bps in 2022.
Over 5 years, Return on Assets stood at 0.0% in 2022, then rose by 4 bps to 0.0% in 2023, then surged by 42 bps to 0.0% in 2024, then grew by 24 bps to 0.0% in 2025, then soared by 60 bps to 0.0% in 2026.
According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.0%, and 0.0% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Abbott Laboratories	198.96 Bn	193.36 Bn	7.27 Bn	0.00%
2	Stryker	127.03 Bn	123.55 Bn	4.50 Bn	0.00%
3	Medtronic	118.36 Bn	109.14 Bn	6.41 Bn	0.00%
4	Boston Scientific	73.13 Bn	72.59 Bn	3.85 Bn	0.00%
5	Edwards Lifesciences	51.68 Bn	47.42 Bn	1.35 Bn	0.00%
6	Dexcom	34.47 Bn	32.52 Bn	830.00 Mn	0.00%
7	GE HealthCare Technologies	33.53 Bn	31.42 Bn	2.18 Bn	0.00%
8	Koninklijke Philips	26.09 Bn	22.77 Bn	4.55 Bn	0.00%
9	Steris	23.03 Bn	22.54 Bn	684.20 Mn	0.00%
10	Cerus	567.60 Mn	511.33 Mn	29.53 Mn	0.00%

Download Data